SAM
BIO icon

Storebrand Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Storebrand Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137
Closed -$38.2K – 769
2026
Q1 		$38.2K Hold
137
– – ﹤0.01% 749
2025
Q4 		$41.5K Hold
137
– – ﹤0.01% 755
2025
Q3 		$38.4K Sell
137
-152
-53% -$41.4K ﹤0.01% 771
2025
Q2 		$69.7K Sell
289
-689
-70% -$163K ﹤0.01% 760
2025
Q1 		$238K Hold
978
– – ﹤0.01% 736
2024
Q4 		$321K Buy
978
+671
+219% +$228K ﹤0.01% 733
2024
Q3 		$103K Sell
307
-119
-28% -$37.8K ﹤0.01% 788
2024
Q2 		$116K Sell
426
-937
-69% -$273K ﹤0.01% 786
2024
Q1 		$471K Sell
1,363
-285
-17% -$93.7K ﹤0.01% 736
2023
Q4 		$532K Buy
1,648
+124
+8% +$38.9K ﹤0.01% 731
2023
Q3 		$546K Buy
1,524
+120
+9% +$46.3K ﹤0.01% 719
2023
Q2 		$532K Buy
1,404
+739
+111% +$301K ﹤0.01% 723
2023
Q1 		$319K Sell
665
-47
-7% -$22K ﹤0.01% 749
2022
Q4 		$299K Hold
712
– – ﹤0.01% 740
2022
Q3 		$297K Sell
712
-268
-27% -$134K ﹤0.01% 745
2022
Q2 		$485K Sell
980
-378
-28% -$197K ﹤0.01% 724
2022
Q1 		$765K Sell
1,358
-345
-20% -$208K ﹤0.01% 697
2021
Q4 		$1.29M Sell
1,703
-655
-28% -$490K 0.01% 688
2021
Q3 		$1.76M Sell
2,358
-823
-26% -$617K 0.01% 664
2021
Q2 		$2.05M Sell
3,181
-1,320
-29% -$803K 0.01% 657
2021
Q1 		$2.57M Hold
4,501
– – 0.01% 623
2020
Q4 		$2.62M Sell
4,501
-307
-6% -$175K 0.02% 597
2020
Q3 		$2.48M Buy
4,808
+201
+4% +$102K 0.02% 576
2020
Q2 		$2.08M Buy
4,607
+3,194
+226% +$1.41M 0.02% 578
2020
Q1 		$495K Buy
+1,413
New +$520K 0.01% 666

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Storebrand Asset Management's BIO Position: Q2 2026 in Review

Storebrand Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 137 shares — an estimated $38.2K sold.

Storebrand Asset Management first reported a position in BIO in Q1 2020 and held it in 25 quarters. The position peaked at $2.62M in Q4 2020. 370 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Storebrand Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Storebrand Asset Management sold 137 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $38.2K.
  • Storebrand Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 25 quarters.
  • Storebrand Asset Management's Bio-Rad Laboratories Class A position peaked at $2.62M in Q4 2020.
  • 370 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.